Intervention (indication) | HTA organisation | Publication date | Consideration of manufacturers’ cost in relation to drug price? |
---|---|---|---|
Eculizumab (PNH) | PBAC | July 2008 | No |
PBAC | March 2009 | No | |
CADTH | February 2010 | No | |
PBAC | July 2010 | No | |
ZIN | May 2016 | Yes | |
ZIN | June 2017 | Yes | |
Eculizumab (aHus) | PBAC | March 2013 | No |
CADTH | July 2013 | No | |
PBAC | March 2014 | No | |
PBAC | August 2014 | No | |
NICE | January 2015 | Yes | |
CADTH | May 2015 | No | |
ZIN | November 2016 | Yes | |
Lumacaftor/ivacaftor (CF) | PBAC | March 2016 | No |
ZIN | May 2016 | Yes | |
NICE | July 2016 | No | |
CADTH | October 2016 | No | |
PBAC | November 2016 | No | |
ZIN | December 2016 | Yes | |
PBAC | July 2017 | No | |
PBAC | July 2018 | No |